Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 23,538 |
|
|||||
| News | - | ||||||
| Day High | 11.40 | Low High |
|||||
| Day Low | 11.17 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Curis Inc | CRIS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0299 | -0.27% | 11.1701 | 14:14:28 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 11.3441 | 11.17 | 11.40 | 11.20 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 128 | 23,538 | $ 11.27 | $ 265,192 | - | 3.80 - 18.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:51:36 | 175 | $ 11.1701 | USD |
Curis Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 65.84M | 5.89M | - | 10.02M | -47.41M | -8.04 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Curis News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRIS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 10.54 | 11.49 | 10.345 | 10.92 | 14,006 | 0.6301 | 5.98% |
| 1 Month | 14.62 | 16.99 | 9.50 | 13.37 | 23,670 | -3.45 | -23.60% |
| 3 Months | 9.70 | 17.49 | 9.50 | 13.69 | 26,809 | 1.47 | 15.16% |
| 6 Months | 10.72 | 17.49 | 8.24 | 12.19 | 43,480 | 0.4501 | 4.20% |
| 1 Year | 16.752 | 18.00 | 3.80 | 12.81 | 145,080 | -5.58 | -33.32% |
| 3 Years | 283.40 | 312.00 | 3.80 | 65.29 | 1,264,840 | -272.23 | -96.06% |
| 5 Years | 30.00 | 348.00 | 3.80 | 96.89 | 1,569,847 | -18.83 | -62.77% |
Curis Description
| Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge. |
